These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2520552)

  • 21. Human leukocyte antigen matching in renal transplantation: review and current status.
    Zmijewski CM
    J Surg Res; 1985 Jan; 38(1):66-87. PubMed ID: 3917516
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of prior third-party blood transfusions on canine renal allograft survival.
    Bull RW; Vriesendorp HM; Obertop H; Bijnen AB; Jeekel J; de Gruijl JJ; Westbroek DL
    Transplantation; 1978 Oct; 26(4):249-54. PubMed ID: 360526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current status of human renal allograft and experimental prolongation of renal graft survival].
    Hirano T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):389-92. PubMed ID: 6386637
    [No Abstract]   [Full Text] [Related]  

  • 24. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
    Singal DP; Joseph S; Szewczuk MR
    Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
    [No Abstract]   [Full Text] [Related]  

  • 26. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
    Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
    Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donor-specific blood transfusions in HLA-D-disparate one-haplotype-related allografts.
    Cochrum KC; Hanes D; Potter D; Vincenti F; Amend W; Feduska N; Perkins H; Salvatierra O
    Transplant Proc; 1979 Dec; 11(4):1903-7. PubMed ID: 161102
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of repeated HLA mismatches on the outcome of renal allograft retransplantation.
    Povlsen JV; Madsen M; Birkeland SA; Løkkegaard H; Pedersen EB; Svejgaard A; Olgaard K; Fjeldborg O
    Transplant Proc; 1992 Feb; 24(1):307-8. PubMed ID: 1539288
    [No Abstract]   [Full Text] [Related]  

  • 30. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
    Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA-A antigen incompatibility and HLA-B antigen compatibility associated with enhanced kidney allograft survival in blood-transfused patients.
    Bućin D
    Exp Clin Immunogenet; 1986; 3(3):138-44. PubMed ID: 3274633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial alloantigens in renal transplantation.
    Paul LC; Baldwin WM; van Es LA
    Transplantation; 1985 Aug; 40(2):117-23. PubMed ID: 3895614
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of blood transfusions and HLA matching on renal transplantation in the Netherlands.
    Persijn GG; van Hooff JP; Kalff MW; Lansbergen Q; van Rood JJ
    Transplant Proc; 1977 Mar; 9(1):503-5. PubMed ID: 325789
    [No Abstract]   [Full Text] [Related]  

  • 34. Elective transfusion or HLA matching.
    Saueracker GC; Dawkins RL; Hurst P; Saker BM; Thatcher G; Haywood EF
    Transplantation; 1980 Nov; 30(5):394-5. PubMed ID: 7006173
    [No Abstract]   [Full Text] [Related]  

  • 35. Transplantation: Donor-specific HLA antibodies and renal allograft failure.
    Loupy A; Jordan SC
    Nat Rev Nephrol; 2013 Mar; 9(3):130-1. PubMed ID: 23399581
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 38. Is it time to prospectively match human leukocyte antigen proteins for lung transplantation?
    Neuringer IP; Aris RM
    Transplantation; 2010 Oct; 90(8):823-4. PubMed ID: 20697323
    [No Abstract]   [Full Text] [Related]  

  • 39. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 40. Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations.
    Fujiwara T; Sakagami K; Haisa M; Kusaka S; Uda M; Kobayashi N; Tanakaya K; Saito S; Matsuno T; Matsuoka J
    Transplant Proc; 1992 Aug; 24(4):1427-8. PubMed ID: 1386699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.